Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-Benzyl 2-azetidinone-4-carboxylate is an organic compound that features a benzyl group attached to a 2-azetidinone-4-carboxylate moiety. It is characterized by its unique structure and properties, making it a versatile molecule for various applications.

72776-05-7

Post Buying Request

72776-05-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

72776-05-7 Usage

Uses

Used in Energy Storage Industry:
(S)-Benzyl 2-azetidinone-4-carboxylate is used as a precursor for the synthesis of its N-acetyl derivative, which serves as a potential candidate for solid electrolyte interphase (SEI)-forming additives in lithium-ion batteries. This application is crucial for enhancing the performance and stability of lithium-ion batteries, which are widely used in various electronic devices and electric vehicles. The N-acetyl derivative contributes to the formation of a stable and efficient SEI layer, improving the overall battery performance and longevity.

Check Digit Verification of cas no

The CAS Registry Mumber 72776-05-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,7,7 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 72776-05:
(7*7)+(6*2)+(5*7)+(4*7)+(3*6)+(2*0)+(1*5)=147
147 % 10 = 7
So 72776-05-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO3/c13-10-6-9(12-10)11(14)15-7-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,12,13)/t9-/m0/s1

72776-05-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (468975)  Benzyl(S)-(−)-4-oxo-2-azetidinecarboxylate  97%

  • 72776-05-7

  • 468975-5G

  • 2,024.10CNY

  • Detail

72776-05-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-BENZYL 2-AZETIDINONE-4-CARBOXYLATE

1.2 Other means of identification

Product number -
Other names benzyl (2S)-4-oxoazetidine-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:72776-05-7 SDS

72776-05-7Synthetic route

dibenzyl L-aspartate
2791-79-9

dibenzyl L-aspartate

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: dibenzyl L-aspartate With chloro-trimethyl-silane; triethylamine In diethyl ether at 0℃; for 1h;
Stage #2: With tert-butylmagnesium chloride In diethyl ether at -5 - 0℃; for 2h;
47%
Stage #1: dibenzyl L-aspartate With chloro-trimethyl-silane In diethyl ether at -78 - 25℃;
Stage #2: With tert-butylmagnesium bromide In diethyl ether at -78 - 25℃;
40%
With chloro-trimethyl-silane; tert-butylmagnesium chloride
(L)-N-(trimethylsilyl)dibenzyl aspartate
72776-06-8

(L)-N-(trimethylsilyl)dibenzyl aspartate

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With tert-butylmagnesium chloride In diethyl ether at 0℃; Yield given;
With tert-butylmagnesium chloride 1.) 0 deg C, 2.) room temperature, overnight; Yield given;
With tert-butylmagnesium chloride In diethyl ether at 0℃;
With tert-butylmagnesium chloride In diethyl ether at -5 - 20℃; for 12.5h;5.1 g
D-aspartic acid dibenzyl ester
4079-59-8

D-aspartic acid dibenzyl ester

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With chloro-trimethyl-silane; tert-butylmagnesium bromide; triethylamine Yield given. Multistep reaction;
dibenzyl L-aspartate
2791-79-9

dibenzyl L-aspartate

methoxy poly(ethylene glycol) sodium salt

methoxy poly(ethylene glycol) sodium salt

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: TEA; 4-dimethylaminopyridine / diethyl ether / 3 h / 0 °C
2: 5.1 g / tBuMgCl / diethyl ether / 12.5 h / -5 - 20 °C
View Scheme
C16H21NO5

C16H21NO5

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With cytochrome P411 expressed in Escherichia coli In aq. phosphate buffer at 20℃; for 24h; pH=8; Catalytic behavior; Enzymatic reaction; enantioselective reaction;n/a
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-(hydroxymethyl)-2-azetidinone
72776-07-9

(S)-4-(hydroxymethyl)-2-azetidinone

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 20℃; Inert atmosphere;100%
With sodium tetrahydroborate In methanol71%
With sodium tetrahydroborate In methanol
With lithium borohydride
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

α-benzyl-L-aspartic acid poly(β-peptide); Monomer(s): α-benzyl-L-aspartic acid β-lactam

α-benzyl-L-aspartic acid poly(β-peptide); Monomer(s): α-benzyl-L-aspartic acid β-lactam

Conditions
ConditionsYield
With magnesium bis(hexamethyldisilazide) In dichloromethane for 0.2h; Product distribution; Further Variations:; Reagents; Solvents; concentrations;100%
With magnesium bis(hexamethyldisilazide) In dichloromethane for 0.2h;100%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-oxo-azetidine-2-carboxylic acid
16404-94-7

(S)-4-oxo-azetidine-2-carboxylic acid

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In tetrahydrofuran for 14h;98%
With hydrogen; palladium 10% on activated carbon In methanol at 25℃; under 760.051 Torr; for 0.5h;93%
With hydrogen; palladium on activated charcoal In isopropyl alcohol at 20℃; under 1140.08 Torr; for 0.333333h;85%
With hydrogen; palladium on activated charcoal In tetrahydrofuran at 25℃; for 0.75h;11.8 g
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(S)-benzyl-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylate
82938-49-6

(S)-benzyl-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With triethylamine98%
With triethylamine97%
With triethylamine In N,N-dimethyl-formamide93%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-Oxo-azetidine-2-carboxylic acid 2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester
372515-10-1

(S)-4-Oxo-azetidine-2-carboxylic acid 2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester

α-3,6,9,12-tetraoxatridecyl-L-aspartic acid, α-benzyl-L-aspartic acid diblock copoly(β-peptide); Monomer(s): α-3,6,9,12-tetraoxatridecyl-L-aspartic acid β-lactam; α-benzyl-L-aspartic acid β-lactam

α-3,6,9,12-tetraoxatridecyl-L-aspartic acid, α-benzyl-L-aspartic acid diblock copoly(β-peptide); Monomer(s): α-3,6,9,12-tetraoxatridecyl-L-aspartic acid β-lactam; α-benzyl-L-aspartic acid β-lactam

Conditions
ConditionsYield
With tris(bistrimethylsilylamine)scandium(III) In dichloromethane at 20℃;95%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(4S)-benzyl N-(tbutoxycarbonyl)-azetidin-2-one-4-carboxylate

(4S)-benzyl N-(tbutoxycarbonyl)-azetidin-2-one-4-carboxylate

Conditions
ConditionsYield
With dmap In acetonitrile for 17h; Ambient temperature;94%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

ortho-toluoyl chloride
933-88-0

ortho-toluoyl chloride

benzyl (S)-1-(2-methylbenzoyl)-4-oxoazetidine-2-carboxylate

benzyl (S)-1-(2-methylbenzoyl)-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;86%
1,1,1,2,2,2-hexamethyldisilane
1450-14-2

1,1,1,2,2,2-hexamethyldisilane

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(4S)-N-(trimethylsilyl)-2-oxoazetidine-4-carboxylic acid benzyl ester
100188-43-0

(4S)-N-(trimethylsilyl)-2-oxoazetidine-4-carboxylic acid benzyl ester

Conditions
ConditionsYield
With saccharin In 1,2-dimethoxyethane for 2h; Heating;78%
2,2-dimethyl-propanol-1
75-84-3

2,2-dimethyl-propanol-1

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-(2,2'-dimethyl)propoxycarbonyl-2-azetidinone

(S)-4-(2,2'-dimethyl)propoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 100℃; for 2h;75%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

2-tolyl isocyanate
614-68-6

2-tolyl isocyanate

benzyl (S)-4-oxo-(o-tolylcarbamoyl)azetidine-2-carboxylate

benzyl (S)-4-oxo-(o-tolylcarbamoyl)azetidine-2-carboxylate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 20℃; for 2h; Inert atmosphere;75%
phosgene
75-44-5

phosgene

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

benzyl (S)-4-oxo-1-(phenylcarbamoyl)azetidine-2-carboxylate
911852-27-2

benzyl (S)-4-oxo-1-(phenylcarbamoyl)azetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: phosgene; aniline With triethylamine In dichloromethane; toluene at 0℃; for 0.5h;
Stage #2: (S)-benzyl 4-oxoazetidine-2-carboxylate In tetrahydrofuran; dichloromethane; toluene
73%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

BOC-L-alanine-NCA
125814-30-4

BOC-L-alanine-NCA

benzyl (S)-1-[(S)-N-(tert-butoxycarbonyl)-alanyl]-4-oxoazetidine-2-carboxylate
321863-81-4

benzyl (S)-1-[(S)-N-(tert-butoxycarbonyl)-alanyl]-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: (S)-benzyl 4-oxoazetidine-2-carboxylate With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h;
Stage #2: BOC-L-alanine-NCA In tetrahydrofuran; hexane at -78℃; for 1h;
71%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

butan-1-ol
71-36-3

butan-1-ol

(S)-4-butoxycarbonyl-2-azetidinone

(S)-4-butoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 100℃; for 2h;69%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

2,6-dimethyl-4-pyrimidinyl p-toluenesulfonate
40227-86-9

2,6-dimethyl-4-pyrimidinyl p-toluenesulfonate

(R)-benzyl 1-(2,6-dimethylpyrimidin-4-yl)-4-oxoazetidine-2-carboxylate
1233503-36-0

(R)-benzyl 1-(2,6-dimethylpyrimidin-4-yl)-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With 1,1'-bis-(diphenylphosphino)ferrocene; potassium carbonate; bis(dibenzylideneacetone)-palladium(0) In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;69%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

isopropyl alcohol
67-63-0

isopropyl alcohol

(S)-4-isopropoxycarbonyl-2-azetidinone
155878-39-0

(S)-4-isopropoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 205℃; for 2h;68%
methanol
67-56-1

methanol

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

methyl (S)-(-)-2-oxoazetidine-4-carboxylate
100188-44-1

methyl (S)-(-)-2-oxoazetidine-4-carboxylate

Conditions
ConditionsYield
With tetrabutoxytitanium at 86℃; for 4h;64%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Benzyl bromoacetate
5437-45-6

Benzyl bromoacetate

benzyl (S)-1-[(benzyloxycarbonyl)methyl]-4-oxoazetidine-2-carboxylate

benzyl (S)-1-[(benzyloxycarbonyl)methyl]-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: (S)-benzyl 4-oxoazetidine-2-carboxylate With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran; hexane at -78℃; for 0.0333333h;
Stage #2: Benzyl bromoacetate In tetrahydrofuran; hexane at -78 - 20℃;
59%
octanol
111-87-5

octanol

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-octoxycarbonyl-2-azetidinone

(S)-4-octoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 80℃; for 2h;58%
2-methyl-propan-1-ol
78-83-1

2-methyl-propan-1-ol

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

2-methyl-1-propyl (S)-(-)-2-oxoazetidine-4-carboxylate
120260-62-0

2-methyl-1-propyl (S)-(-)-2-oxoazetidine-4-carboxylate

Conditions
ConditionsYield
With tetrabutoxytitanium at 85℃; for 2h;58%
With tetrabutoxytitanium
1-dodecyl alcohol
112-53-8

1-dodecyl alcohol

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-dodecoxycarbonyl-2-azetidinone

(S)-4-dodecoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 105℃; for 4h;58%
Cyclopentanol
96-41-3

Cyclopentanol

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-cyclopentoxycarbonyl-2-azetidinone

(S)-4-cyclopentoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 85℃; for 2h;56%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

cyclohexanol
108-93-0

cyclohexanol

(S)-4-cyclohexoxycarbonyl-2-azetidinone

(S)-4-cyclohexoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 105℃; for 3h;56%
1-octadecanol
112-92-5

1-octadecanol

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

(S)-4-octadecoxycarbonyl-2-azetidinone

(S)-4-octadecoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 91℃; for 4h;51%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

hexan-1-ol
111-27-3

hexan-1-ol

(S)-4-hexoxycarbonyl-2-azetidinone

(S)-4-hexoxycarbonyl-2-azetidinone

Conditions
ConditionsYield
With tetrabutoxytitanium at 85℃; for 2h;47%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

4-isopropyl-2,5-dioxo-oxazolidine-3-carboxylic acid-tert-butyl ester
141468-55-5

4-isopropyl-2,5-dioxo-oxazolidine-3-carboxylic acid-tert-butyl ester

benzyl (S)-1-[(S)-N-(tert-butoxycarbonyl)-valyl]-4-oxoazetidine-2-carboxylate

benzyl (S)-1-[(S)-N-(tert-butoxycarbonyl)-valyl]-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: (S)-benzyl 4-oxoazetidine-2-carboxylate With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h;
Stage #2: 4-isopropyl-2,5-dioxo-oxazolidine-3-carboxylic acid-tert-butyl ester In tetrahydrofuran; hexane at -78℃; for 1h;
41%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

Z-L-Ala-NCA

Z-L-Ala-NCA

benzyl (S)-1-[(S)-N-(benzyloxycarbonyl)-alanyl]-4-oxoazetidine-2-carboxylate

benzyl (S)-1-[(S)-N-(benzyloxycarbonyl)-alanyl]-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: (S)-benzyl 4-oxoazetidine-2-carboxylate With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h;
Stage #2: Z-L-Ala-NCA In tetrahydrofuran; hexane at -78℃; for 1h;
37%
tert-butyl(4-(isocyanatomethyl)phenyl)carbamate

tert-butyl(4-(isocyanatomethyl)phenyl)carbamate

(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

benzyl (S)-1-(4-tert-butoxycarbonylaminobenzylcarbamoyl)-4-oxoazetidine-2-carboxylate

benzyl (S)-1-(4-tert-butoxycarbonylaminobenzylcarbamoyl)-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
Stage #1: (S)-benzyl 4-oxoazetidine-2-carboxylate With sodium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.25h; Inert atmosphere;
Stage #2: tert-butyl(4-(isocyanatomethyl)phenyl)carbamate In tetrahydrofuran at -78℃; for 0.5h; Inert atmosphere;
37%
(S)-benzyl 4-oxoazetidine-2-carboxylate
72776-05-7

(S)-benzyl 4-oxoazetidine-2-carboxylate

tert-butyl 2-(fluorocarbonyl)pyrrolidine-1-carboxylate
133010-05-6

tert-butyl 2-(fluorocarbonyl)pyrrolidine-1-carboxylate

benzyl N-[N-(tert-butoxycarbonyl)-prolyl]-4-oxoazetidine-2-carboxylate

benzyl N-[N-(tert-butoxycarbonyl)-prolyl]-4-oxoazetidine-2-carboxylate

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran; hexane at -78 - 20℃;20%

72776-05-7Relevant articles and documents

RETRACTED ARTICLE: Site-selective enzymatic C-H amidation for synthesis of diverse lactams

Cho, Inha,Jia, Zhi-Jun,Arnold, Frances H.

, p. 575 - 578 (2019/06/07)

A major challenge in carbon?hydrogen (C?H) bond functionalization is to have the catalyst control precisely where a reaction takes place. In this study, we report engineered cytochrome P450 enzymes that perform unprecedented enantioselective C?H amidation reactions and control the site selectivity to divergently construct b-, g-, and d-lactams, completely overruling the inherent reactivities of the C?H bonds. The enzymes, expressed in Escherichia coli cells, accomplish this abiological carbon?nitrogen bond formation via reactive iron-bound carbonyl nitrenes generated from nature-inspired acyl-protected hydroxamate precursors. This transformation is exceptionally efficient (up to 1,020,000 total turnovers) and selective (up to 25:1 regioselectivity and 97%, please refer to compound 2v enantiomeric excess), and can be performed easily on preparative scale.

The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain

Brown, Alan D.,Bagal, Sharan K.,Blackwell, Paul,Blakemore, David C.,Brown, Bruce,Bungay, Peter J.,Corless, Martin,Crawforth, James,Fengas, David,Fenwick, David R.,Gray, Victoria,Kemp, Mark,Klute, Wolfgang,Malet Sanz, Laia,Miller, Duncan,Murata, Yoshihisa,Payne, C. Elizabeth,Skerratt, Sarah,Stevens, Edward B.,Warmus, Joseph S.

, p. 230 - 239 (2018/12/11)

The voltage gated sodium channel NaV1.8 has been postulated to play a key role in the transmission of pain signals. Core hopping from our previously reported phenylimidazole leads has allowed the identification of a novel series of benzimidazole NaV1.8 blockers. Subsequent optimization allowed the identification of compound 9, PF-06305591, as a potent, highly selective blocker with an excellent preclinical in vitro ADME and safety profile.

Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives

Galletti, Paola,Soldati, Roberto,Pori, Matteo,Durso, Margherita,Tolomelli, Alessandra,Gentilucci, Luca,Dattoli, Samantha Deianira,Baiula, Monica,Spampinato, Santi,Giacomini, Daria

, p. 284 - 293 (2014/07/08)

The αvβ3 and α5β 1 integrins are widely expressed in different cancer types and recognize the tripeptide Arg-Gly-Asp (RGD) motif present in several extracellular matrix proteins. We report here the design, synthesis and biological activity of some new β-lactam derivatives specifically designed to target integrins. The new molecules contain the azetidinone as the only cyclic framework armed with carboxylic acid and amine terminals spaced from 9 to 14 atoms to switch on recognition by integrins. All tested molecules showed a concentration-dependent enhancement in fibronectin-mediated adhesion of K562 and SK-MEL-24 cells; in particular 1, expressed a higher affinity towards α5β1 integrin (EC50 of 12 nM) and 2 was more selective for integrin αvβ3 (EC 50 of 11 nM).

Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders

-

Page/Page column 45, (2010/11/26)

The present invention provides 4-substituted-2-azetidinone compounds, bicyclic 2-5-diketopiperazine compounds, and pharmaceutical compositions thereof that are potent, safe and effective neuroprotective agents. Due to their strong central nervous system (CNS) activity, the compounds can be used to enhance memory and to treat a variety of neurological disorders. The compounds are particularly useful for treating neurological disorders caused by, or associated with, CNS trauma.

β-Lactam derivatives as enzyme inhibitors: N-substituted derivatives of (S)-4-oxoazetidine-2-carboxylate as inhibitors of elastase and papain

Achilles,Schneider,Schirmeister,Otto

, p. 798 - 802 (2007/10/03)

N-Alkyl and N-acyl substituted 4-oxoazetidine-2-carboxylates are synthesized and evaluated as inhibitors of the proteases porcine pancreatic elastase (PPE) and papain. The compounds are obtained by alkylation or acylation at the nitrogen of benzyl (S)-4-oxoazetidine-2-carboxylate, which is synthesized by a modified literature procedure. The enzymatic assays prove some derivatives to be effective inhibitors of PPE and/or papain. The N-BOC protected amino acid derivatives 10 and 13 inhibit PPE reversibly with K(I)-values in the micromolar range. On the other hand, papain is inactivated irreversibly by benzyl (S)-2-(benzyloxycarbonyl)azetidin-1-acetate (6).

Synthesis and biology of the rigidified glutamate analogue, trans-2-carboxyazetidine-3-acetic acid (t-CAA)

Kozikowski, Alan P.,Liao, Yi,Tueckmantel, Werner,Wang, Shaomeng,Pshenichkin, Sergey,Surin, Alexander,Thomsen, Christian,Wroblewski, Jarda T.

, p. 2559 - 2564 (2007/10/03)

Chemical approaches to the (-)- and (+)-trans-2-carboxyazetidine-3-acetic acids (-)-1 and (+)-1, and their homologues (-)-2 and (+)-2, compounds that represent rigidified analogues of glutamate (glu), are reported together with the complete biological characterization of (+)-1 (t-CAA) at the known glu recognition sites. t-CAA was found to be an inhibitor of Na+-dependent glu uptake and to act as a kainate receptor ligand.

Studies on the Alkylation of Dipeptide Substrates

Ager, David J.,Froen, Diane E.,Klix, Russell C.,Zhi, Benxin,McIntosh, John M.,Thangarasa, Rasiah

, p. 1975 - 1982 (2007/10/02)

Alkylation of anions derived from dipeptides with a glycine at the C-terminus have been investigated.A hydrocarbon sedition in the N-terminal residue does impart some asymmetric induction.The use of a chiral ester derivative provides the potential for double asymmetric induction and good selectivity.With an aspartyl residue at the N-terminus, problems were encountered due to competing side reactions.The use of an azetidione could circumvent some of these, but the observed induction was not high.

STEREOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN

Baldwin, Jack E.,Adlington, Robert M.,Gollins, David W.,Schofield, Christopher J.

, p. 4733 - 4748 (2007/10/02)

The first synthesis of the novel α-amino acid dealanylalahopcin starting from (L)-aspartic acid is described.

A Stereoselective Approach to the δ-Lactone Fragment of the Lankacidin Antibiotics

Thomas, Eric J.,Williams, Andrew C.

, p. 992 - 994 (2007/10/02)

An approach to the synthesis of the lactone fragment of the lankacidin antibiotics is described which is based upon stereoselective modification of an L-aspartic acid derived β-lactam.

The Asymmetric Addition of the Sn(II) Enolates of Thioesters to α-Iminoesters. A Convenient Synthesis of Optically Active cis-Substituted β-Lactams.

Yamada, Tohru,Suzuki, Hiroshi,Mukaiyama, Teruaki

, p. 293 - 296 (2007/10/02)

The asymmetric addition of the Sn(II) enolates derived from thioesters to α-iminoesters having the chiral auxiliary on the nitrogen atom proceeds smoothly to afford syn-β-aminoacid derivatives, which are in turn converted to optically active cis-substituted β-lactams.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 72776-05-7